Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
Cheng S, Arciero V, Goldberg H, Tajzler C, Manganaro A, Kozlowski N, Rowbottom L, McDonald R, Chow R, Vasisht G, Shaji S, Wong ECL, Petrovic M, Zhang L, Phillips C, Zalewski P, Kapoor A, Fleshner NE, Chow E, Emmenegger U. Cheng S, et al. Cancer Manag Res. 2019 Oct 31;11:9307-9319. doi: 10.2147/CMAR.S213051. eCollection 2019. Cancer Manag Res. 2019. PMID: 31802949 Free PMC article.
Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?
Cheng S, McDonald EJ, Cheung MC, Arciero VS, Qureshi M, Jiang D, Ezeife D, Sabharwal M, Chambers A, Han D, Leighl N, Sabarre KA, Chan KKW. Cheng S, et al. J Clin Oncol. 2017 Aug 20;35(24):2764-2771. doi: 10.1200/JCO.2016.71.6894. Epub 2017 Jun 2. J Clin Oncol. 2017. PMID: 28574778
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Chan KKW, Guo H, Cheng S, Beca JM, Redmond-Misner R, Isaranuwatchai W, Qiao L, Earle C, Berry SR, Biagi JJ, Welch S, Meyers BM, Mittmann N, Coburn N, Arias J, Schwartz D, Dai WF, Gavura S, McLeod R, Kennedy ED. Chan KKW, et al. Among authors: cheng s. Cancer Med. 2020 Jan;9(1):160-169. doi: 10.1002/cam4.2705. Epub 2019 Nov 13. Cancer Med. 2020. PMID: 31724340 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33704163
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer.
Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, Balaratnam K, Khan K, Patel D, Grant B, Raptis R, Brown MC, Xu W, Moriarty P, Shepherd FA, Sacher AG, Leighl NB, Bradbury PA, Liu G. Schmid S, et al. Among authors: cheng s. Clin Lung Cancer. 2023 Jan;24(1):40-50. doi: 10.1016/j.cllc.2022.09.007. Epub 2022 Sep 24. Clin Lung Cancer. 2023. PMID: 36270866
13,273 results
You have reached the last available page of results. Please see the User Guide for more information.